Rachel Margolis-Goodman: Every Contribution Matters. Together, We Research Cures
Rachel Margolis-Goodman, Director of Advancement for the Versiti Blood Research Institute, shared on LinkedIn:
”It is hard to believe after a wonderful week with family and some online shopping, Giving Tuesday is here!
This past year, I decided to completely change my career and entered the fundraising world, and I am so grateful I did.
So on this giving Tuesday, perhaps you could consider giving back to the Versiti Blood Research Institute or Versiti on King!
Both the VBRI and Versiti on King is transforming blood health together!
From breakthrough research in our labs to trusted partnerships in our communities, Versiti is driving change at every level.
At Versiti Blood Research Institute, scientists are researching cures every day with the hope to eradicate blood disease.
At the VBRI we are driving breakthroughs in blood health, from stem cell biology to immunology.
This cutting edge research saves lives and will help shape the future of medicine.
Through Versiti on King (VOK), we’re connecting neighbors to resources, hosting blood typing events, community education events, and partnering with communities to improve health equity.
Through our programs this year, 170 people discovered they carry Ro-positive blood, the safest type for patients with sickle cell disease.
If you are unable to donate financially, please consider scheduling a blood donation today to help save up to 3 lives!
Every contribution matters. Together, we research cures.
Make your Giving Tuesday gift:
Stay updated on the emerging with Hemostasis Today.
-
Sep 11, 2026, 09:51Alfredo Lozada: Pelacarsen Lowers Lp(a), But Does It Lower CV Risk?
-
Sep 11, 2026, 09:35Yasir Khan: Travel Related Blood Clots – What Are the Chances?
-
Sep 11, 2026, 08:02Mud Alvi: Restarting Antithrombotic Therapy After Hemorrhagic Transformation of Ischemic Stroke
-
Sep 11, 2026, 08:01Chaza Alaji: Factor X From Inherited Deficiency to Acquired Deficiency in AL Amyloidosis
-
Sep 11, 2026, 08:01Mariusz Kowalewski: Risk Stratification of Surgical Ablation During Minimally Invasive Mitral Valve Surgery for AFib
-
Sep 11, 2026, 08:00Noor Gajraj: MTHFR Helps Turn Folate, Vitamin B9, Into The Form The Body Uses
-
Sep 11, 2026, 07:59Lisa Lacy: Living With Hereditary Antithrombin Deficiency and the Constant Threat of Clotting
-
Sep 11, 2026, 03:10Chris Oung: Anticoagulation for Atrial Fibrillation with Intermediate Stroke Risk
-
Sep 10, 2026, 21:33J. Meireles-Brandao: Lp(a)HORIZON and the Role of Inflammation in ASCVD